Panacea Biotec reported zero shares dematerialized during March 2026 as per SEBI Regulation 74(5).
Total dematerialized shares stood at 6.11 crore as of March 31, 2026, split between NSDL (5.36 crore) and CDSL (75.53 lakh).
The company submitted a confirmation certificate from its RTA, Skyline Financial Services Pvt. Ltd., verifying the demat status.